STRASS 2 clinical trial receives MRFF funding - Cooper Rice-Brading Foundation
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
Current Oncology | Free Full-Text | Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation
2022 July - ANZSA report | COSA
Quality Assurance Of Radiotherapy In STRASS Trial Shows Importance Of Its Inclusion In Trial Development 2023 - EORTC
Soft tissue sarcoma (Retroperitoneal Sarcoma)
SARCOMA CONNECT on Twitter: "https://t.co/WXMOZSR4zK ⚡#Sarcoma . Comparison of #STRASS and #STREXIT data published in @AnnalsofSurgery :preoperative RT associated with better ARFS in patients with #liposarcoma. #MedED #oncology" / Twitter
Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-b
Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial | RMD Open
PDF) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: Results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ...
EORTC 1809 STRASS II Trial In Retroperitoneal Sarcoma Receives Support By The Anticancer Fund 2023 - EORTC
SARCOMA CONNECT on Twitter: "https://t.co/WXMOZSR4zK ⚡#Sarcoma . Comparison of #STRASS and #STREXIT data published in @AnnalsofSurgery :preoperative RT associated with better ARFS in patients with #liposarcoma. #MedED #oncology" / Twitter
Alessandro Gronchi on Twitter: "@SprakerMDPhD @ASTRO_org @TARPSWG In addition unfortunately #STRASS didn't show any LC benefit, save for the liposarcoma subgroup. And for G1-2 only. Stay tuned... #STREXIT study results (pts treated off trial by ...
Raising awareness for Sarcoma 2023 - EORTC Cancer Research Fund
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Updates in Sarcoma Benjamin Powers, MD June ppt download
The STRASS trial: an important step in the right direction - The Lancet Oncology
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group | SpringerLink
Flow chart of the STRASS RCT and the 3-year extension study - ppt download
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2) | SpringerLink
Retroperitoneal Sarcoma: a STRASS II Q&A 2023 - EORTC Cancer Research Fund
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
EORTC 1809 Strass II Trial Receives Strong Support from Anticancer Fund
Flowchart of the patients enrolled in the STRASS trial cost-utility... | Download Scientific Diagram
